Get the Stockscreener App
28.18
1.67%
-0.48
Pre-market:
28.39
0.21
+0.75%
Lakefront Biotherapeutics Nv Adr stock is traded at $28.18, with a volume of 199.97K.
It is down -1.67% in the last 24 hours and up +4.18% over the past month.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
See More
Previous Close:
$28.66
Open:
$28.43
24h Volume:
199.97K
Relative Volume:
2.75
Market Cap:
$1.86B
Revenue:
$1.21B
Net Income/Loss:
$570.23M
P/E Ratio:
3.2551
EPS:
8.6571
Net Cash Flow:
$-293.03M
1W Performance:
-0.32%
1M Performance:
+4.18%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$27.95
$28.44
1-Week Range:
$27.95
$29.33
52-Week Range:
$26.42
$29.33
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Company Profile
Name
Lakefront Biotherapeutics Nv Adr
Sector
Industry
Phone
-
Address
-
Compare LKFT vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LKFT
Lakefront Biotherapeutics Nv Adr
|
28.18 | 1.89B | 1.21B | 570.23M | -293.03M | 8.6571 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Latest News
Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com
Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated - Bez Kabli
LKFT.AS Stock Price, Quote & Chart | LAKEFRONT BIOTHERAPEUTICS (AMS:LKFT) - ChartMill
Lakefront Receives Transparency Notification from Bank of America - Yahoo Finance Australia
LKFT Technical Analysis | Trend, Signals & Chart Patterns | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
LKFT Stock Chart | LAKEFRONT BIOTHERAPEUTIC-ADR (NASDAQ:LKFT) - ChartMill
What is the current Price Target and Forecast for Lakefront BiotherapeuticsSponsored ADR (LKFT) - Zacks Investment Research
Earnings call transcript: Galapagos NV sees 91% revenue drop in Q1 2026 - Investing.com
LKFT: Lakefront BiotherapeuticsSponsored ADRCash Flow Statements - Zacks Investment Research
LKFT : Lakefront BiotherapeuticsSponsored Adr Key Company Details - Zacks Investment Research
Lakefront BiotherapeuticsSponsored ADR (LKFT) Return On Equity (TTM) - Zacks Investment Research
Lakefront Biotherapeutics NV Stock Baskets - GuruFocus
Lakefront Biotherapeutics (NASDAQ: GLPG) outlines ADR deposit terms - Stock Titan
LKFT Stock Price and Chart — NASDAQ:LKFT - TradingView
LKFT Stock Price and Chart — EURONEXT:LKFT - TradingView
Earnings call transcript: Galapagos Q1 2026 beats EPS, revenue falls short - Investing.com
Galapagos (GLPG) posts Q1 2026 profit and commits up to €790M to Ouro deal - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
ActivePassive International Equity ETF Holdings - Quiver Quantitative
Lakefront Biotherapeutics Nv Adr Stock (LKFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):